MGMT and neoplasm: The biological reasons for these observations are as yet unclear, although molecular characterization reveals that females are more likely to have MGMT methylated disease, secondary GBMs, differences in tumor location, and molecular and metabolic mechanistic triggers [2,3,4,5,6].